Systemic Inflammatory Markers In Vocal Cord Lesions
Trial statusNot yet recruiting
Trial phaseNot listed
Trial typeObservational
Biological sexAll
Age18+
SponsorAntalya Health Sciences University
About this trial
The aim of this study is to evaluate the levels of systemic inflammatory markers such as PIV, SII, and NPAR in patients with benign and premalignant laryngeal lesions and to determine the diagnostic accuracy of these values using ROC analysis.
Eligibility criteria
Qualifiers
Patients aged 18 years and older
Patients with a diagnosis of vocal cord lesion via endoscopic or surgical means
Patients with complete blood count and albumin data in their hospital records
Disqualifiers
Acute infection
Autoimmune disease
Other malignancy
Steroid use
Trial design
Treatments tested in this trial
- Laryngeal polyps
- Laryngeal nodules
- Laryngeal cysts
- Reinke's edema
- Papillomas
- Dysplasia
- High-risk premalignant lesions
- Malignant vocal cord lesions
- Asymptomatic smokers without vocal cord lesions
Treatment groups
250 Participants
are divided into 9 treatment groups9
Treatment groupsSee each treatment group below.
Sponsors and collaborators
Source ClinicalTrials.gov